Memorial Sloan Kettering Cancer Center

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
MPN
COVID-19
Events

Playback speed

10 seconds

Hematopoietic Stem Cell Transplant: Difference Between AutoHSCT and AlloHSCT, Overcoming AE of Mismatched HSCT, Prognostic Models & Conditioning Regimen Effects

By Memorial Sloan Kettering Cancer Center FEATURING Miguel-Angel Perales

45 views

March 25, 2020

Comments 0

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Hematologic Transplantation and Malignancies

ASH 2023 Insights: "Validation of the Composite CR Definitions in th…

Insights from 2023 ASH Annual Meeting

J. Bewersdorf

108 views

ASH 2022: Management of Accelerated and Blast-Phase MPN

ASH 2022 Conference Coverage

R. Rampal

57 views

MDS Foundation ASH 2021 Review: Towards a Genetically Inspired Class…

MDS Foundation

E. Bernard

73 views

ASH 2021: Evaluation of IWG 2006 Response Criteria in Patients with …

ASH 2021 Conference Coverage on VuMedi

J. Bewersdorf

123 views

Which Published Schemas Are Helpful in MPN Transplant Decisions?

2021 International Congress on Myeloproliferative Neoplasms

S. Giralt

12 views

SOHO 2021 Update on NY-ESO-1 TCR T-Cell Therapy

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

A. Schoenfeld

44 views

SOHO 2021: A Tumor-Agnostic TCR-Mimic CAR T-Cell Specific for NDC80 …

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

M. Klatt

27 views

2021 SOHO Highlights on CARs for Solid Tumors

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

R. O'Cearbhaill

6 views

CAR-T State of the Art: What Therapies Will Be Available in the Next…

SOHO Highlights: State of the Art and Next Questions

S. Giralt

40 views

2020 SOHO Highlights on CARs: How Does the Ideal Next-Gen CAR T-Cell…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

R. Brentjens

135 views

2020 SOHO Highlights on Myelofibrosis: What Is the Distinctive Featu…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

R. Rampal

358 views

IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of R…

University of Miami's 2nd Biennial Miami Leukemia Symposium

E. Stein

228 views

Hematopoietic Stem Cell Transplant: Difference Between AutoHSCT and …

Memorial Sloan Kettering Cancer Center

M. Perales

45 views

Complication of AlloHSCT: Phases of Complications, Classification of…

Memorial Sloan Kettering Cancer Center

M. Perales

321 views

CNS Toxicity of CAR-T in Hematologic Malignancies: Clinical Manifest…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

B. Santomasso

19 views

Setting Up a CAR T Program Ins and Outs: Institutional Program Devel…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

S. Giralt

29 views

Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokin…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

B. Santomasso

31 views